# Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase

> **NCT02036255** · PHASE3 · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 68 (actual)

## Conditions studied

- Patency
- Infection

## Interventions

- **DRUG:** Taurolidine Urokinase
- **DRUG:** Taurolidine Heparin

## Key facts

- **NCT ID:** NCT02036255
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-07
- **Final completion:** 2018-05
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036255, "Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02036255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*